195 related articles for article (PubMed ID: 25924666)
41. Treatment of hypogonadism with testosterone in patients with type 2 diabetes mellitus.
Gopal RA; Bothra N; Acharya SV; Ganesh HK; Bandgar TR; Menon PS; Shah NS
Endocr Pract; 2010; 16(4):570-6. PubMed ID: 20150021
[TBL] [Abstract][Full Text] [Related]
42. Systemic and vascular markers of inflammation in relation to metabolic syndrome and insulin resistance in adults with elevated atherosclerosis risk.
Kressel G; Trunz B; Bub A; Hülsmann O; Wolters M; Lichtinghagen R; Stichtenoth DO; Hahn A
Atherosclerosis; 2009 Jan; 202(1):263-71. PubMed ID: 18501910
[TBL] [Abstract][Full Text] [Related]
43. Triglyceride-glucose index levels in patients with Klinefelter syndrome and its relationship with endothelial dysfunction and insulin resistance: a cross-sectional observational study.
Demirci I; Haymana C; Candemir B; Yuksel B; Eser M; Meric C; Akin S; Gulcelik NE; Sonmez A
Arch Endocrinol Metab; 2023 Mar; 67(3):378-384. PubMed ID: 37011373
[TBL] [Abstract][Full Text] [Related]
44. Testosterone and metabolic syndrome: a meta-analysis study.
Corona G; Monami M; Rastrelli G; Aversa A; Tishova Y; Saad F; Lenzi A; Forti G; Mannucci E; Maggi M
J Sex Med; 2011 Jan; 8(1):272-83. PubMed ID: 20807333
[TBL] [Abstract][Full Text] [Related]
45. The role of androgen receptor CAG repeat polymorphism and other factors which affect the clinical response to testosterone replacement in metabolic syndrome and type 2 diabetes: TIMES2 sub-study.
Stanworth RD; Akhtar S; Channer KS; Jones TH
Eur J Endocrinol; 2014 Feb; 170(2):193-200. PubMed ID: 24165020
[TBL] [Abstract][Full Text] [Related]
46. Lipid accumulation product is a powerful index for recognizing insulin resistance in non-diabetic individuals.
Xia C; Li R; Zhang S; Gong L; Ren W; Wang Z; Li Q
Eur J Clin Nutr; 2012 Sep; 66(9):1035-8. PubMed ID: 22781025
[TBL] [Abstract][Full Text] [Related]
47. Longitudinal factor analysis reveals a distinct clustering of cardiometabolic improvements during intensive, short-term dietary and exercise intervention in obese children and adolescents.
Hobkirk JP; King RF; Gately P; Pemberton P; Smith A; Barth JH; Carroll S
Metab Syndr Relat Disord; 2012 Feb; 10(1):20-5. PubMed ID: 21936669
[TBL] [Abstract][Full Text] [Related]
48. Testosterone therapy reduces insulin resistance in men with adult-onset testosterone deficiency and metabolic syndrome. Results from the Moscow Study, a randomized controlled trial with an open-label phase.
Tishova Y; Kalinchenko S; Mskhalaya G; Hackett G; Livingston M; König C; Strange R; Zitzmann M; Mann A; Maarouf A; Ramachandran S
Diabetes Obes Metab; 2024 Jun; 26(6):2147-2157. PubMed ID: 38433502
[TBL] [Abstract][Full Text] [Related]
49. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
[TBL] [Abstract][Full Text] [Related]
50. Effect of chronic cabergoline treatment and testosterone replacement on metabolism in male patients with prolactinomas.
Auriemma RS; Galdiero M; Vitale P; Granieri L; Lo Calzo F; Salzano C; Ferreri L; Pivonello C; Cariati F; Coppola G; de Angelis C; Colao A; Pivonello R
Neuroendocrinology; 2015; 101(1):66-81. PubMed ID: 25592453
[TBL] [Abstract][Full Text] [Related]
51. Obesity indices and metabolic markers are related to hs-CRP and adiponectin levels in overweight and obese females.
Sanip Z; Ariffin FD; Al-Tahami BA; Sulaiman WA; Rasool AH
Obes Res Clin Pract; 2013; 7(4):e315-20. PubMed ID: 24306161
[TBL] [Abstract][Full Text] [Related]
52. Pioglitazone for treating polycystic ovary syndrome in non-obese women of reproductive age with different clinical presentations.
Koo YA; Shin SY; Yoon BK; Choi D
Gynecol Endocrinol; 2007; 23(8):461-7. PubMed ID: 17852414
[TBL] [Abstract][Full Text] [Related]
53. [Hypogonadism may cause insulin resistance in young males].
Mao JF; Wu XY; Li NS; Shi YF
Zhonghua Nan Ke Xue; 2006 Jul; 12(7):612-4. PubMed ID: 16894938
[TBL] [Abstract][Full Text] [Related]
54. Low-intermediate dose testosterone replacement therapy by different pharmaceutical preparations improves frailty score in elderly hypogonadal hyperglycaemic patients.
Strollo F; Strollo G; Morè M; Magni P; Macchi C; Masini MA; Carucci I; Celotti F; Ruscica M; Gentile S
Aging Male; 2013 Jun; 16(2):33-7. PubMed ID: 23517433
[TBL] [Abstract][Full Text] [Related]
55. Is hypoandrogenemia a component of metabolic syndrome in males?
Singh SK; Goyal R; Pratyush DD
Exp Clin Endocrinol Diabetes; 2011 Jan; 119(1):30-5. PubMed ID: 20690073
[TBL] [Abstract][Full Text] [Related]
56. Efficacy of testosterone replacement therapy for treating metabolic disturbances in late-onset hypogonadism: a systematic review and meta-analysis.
Kim SH; Park JJ; Kim KH; Yang HJ; Kim DS; Lee CH; Jeon YS; Shim SR; Kim JH
Int Urol Nephrol; 2021 Sep; 53(9):1733-1746. PubMed ID: 34089171
[TBL] [Abstract][Full Text] [Related]
57. Effects of long-term treatment with testosterone on weight and waist size in 411 hypogonadal men with obesity classes I-III: observational data from two registry studies.
Saad F; Yassin A; Doros G; Haider A
Int J Obes (Lond); 2016 Jan; 40(1):162-70. PubMed ID: 26219417
[TBL] [Abstract][Full Text] [Related]
58. Male hypogonadism and metabolic syndrome.
Naifar M; Rekik N; Messedi M; Chaabouni K; Lahiani A; Turki M; Abid M; Ayedi F; Jamoussi K
Andrologia; 2015 Jun; 47(5):579-86. PubMed ID: 25040289
[TBL] [Abstract][Full Text] [Related]
59. Insulin resistance is the best predictor of the metabolic syndrome in subjects with a first-degree relative with type 2 diabetes.
Utzschneider KM; Van de Lagemaat A; Faulenbach MV; Goedecke JH; Carr DB; Boyko EJ; Fujimoto WY; Kahn SE
Obesity (Silver Spring); 2010 Sep; 18(9):1781-7. PubMed ID: 20379148
[TBL] [Abstract][Full Text] [Related]
60. Decreased high-density lipoprotein cholesterol is associated with inflammation and insulin resistance in non-diabetic haemodialysis patients.
Peng YS; Chiu YL; Chen HY; Yang JY; Lai CF; Hsu SP; Pai MF
Nephrology (Carlton); 2010 Oct; 15(7):692-9. PubMed ID: 21040164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
